Acquipharma
Africa, NA - South Africa, South Africa, Johannesburg'%3e%3cpath fill='%23001489' d='M0 0v6h9V0z'/%3e%3cpath fill='%23e03c31' d='M0 0v3h9V0z'/%3e%3cg stroke='%23fff' stroke-width='2'%3e%3cpath id='d' d='m0 0 4.5 3L0 6m4.5-3H9'/%3e%3cuse xlink:href='%23b' stroke='%23ffb81c' clip-path='url(%23c)'/%3e%3c/g%3e%3cuse xlink:href='%23d' fill='none' stroke='%23007749' stroke-width='1.2'/%3e%3c/g%3e%3c/svg%3e)
Description
Acquipharma is headed by Oppel Greeff, a medical doctor and a former executive with publicly traded Quintiles Transnational Corp.
Investor Profile
Acquipharma has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B rounds (top funding stages).
- Majority of deals are located in India.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series B (100%)
Country Focus
- India (100%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Pharmaceutical
- Product Research
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.